Variant report
Variant | esv3410667 |
---|---|
Chromosome Location | chr3:68677937-68680260 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533362322 | chr3:68677941-68677942 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558290167 | chr3:68677954-68677955 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375360991 | chr3:68677963-68677964 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139152776 | chr3:68678057-68678058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369042614 | chr3:68678123-68678124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144073308 | chr3:68678144-68678145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371407439 | chr3:68678169-68678170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549625387 | chr3:68678178-68678179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529835385 | chr3:68678189-68678190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371697346 | chr3:68678192-68678193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565764650 | chr3:68678199-68678200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1511910 | chr3:68678211-68678212 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs188855750 | chr3:68678235-68678236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111799128 | chr3:68678280-68678281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571116469 | chr3:68678283-68678284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112588449 | chr3:68678303-68678304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556973943 | chr3:68678374-68678375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111736038 | chr3:68678379-68678380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34224188 | chr3:68678429-68678430 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs536024655 | chr3:68678441-68678442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116732695 | chr3:68678444-68678445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183124675 | chr3:68678445-68678446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377667525 | chr3:68678481-68678482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554930451 | chr3:68678624-68678625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541077351 | chr3:68678638-68678639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187082008 | chr3:68678662-68678663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564248037 | chr3:68678681-68678682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34623247 | chr3:68678754-68678755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577946278 | chr3:68678763-68678764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543844777 | chr3:68678765-68678766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1847488 | chr3:68678782-68678783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529626180 | chr3:68678796-68678797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1847489 | chr3:68678812-68678813 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs1847490 | chr3:68678822-68678823 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs1847491 | chr3:68678828-68678829 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs183642660 | chr3:68678845-68678846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189283335 | chr3:68678850-68678851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536622464 | chr3:68678856-68678857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550587113 | chr3:68678864-68678865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs193298408 | chr3:68678873-68678874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536115617 | chr3:68678878-68678879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557286421 | chr3:68678897-68678898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185082872 | chr3:68678903-68678904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190372823 | chr3:68678935-68678936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181789901 | chr3:68678970-68678971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185595251 | chr3:68678992-68678993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562753739 | chr3:68679045-68679046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572658580 | chr3:68679078-68679079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538483618 | chr3:68679105-68679106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs13089038 | chr3:68679114-68679115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Breast cancer | 17142309 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:68676600-68678000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:68676600-68679800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr3:68677600-68680400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr3:68678000-68680800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr3:68679800-68680000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr3:68680000-68680400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr3:68680000-68680800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr3:68680000-68680800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr3:68680000-68681000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr3:68680200-68680800 | Enhancers | HUES48 Cell Line | embryonic stem cell |